The new clinical frontier is chimera sequences. Such designed molecules merge sections from various peptide origins, allowing the development of unique therapeutic properties. This method presents a promising https://chimerapeptides746412.itbloghub.com/832050/chimera-peptides-a-novel-therapeutic-frontier